Joseph Pitts said...

This has been a very interesting hearing, very important issue, very informative.

Pitts summarizes the importance of the hearing on telemedicine.

03/19/2013

More Joseph Pitts Quotes

In 2009, this committee passed the Biologics Price Competition and Innovation Act (BPCIA) by a vote of 47 to 11.

FDA approved the first biosimilar in March 2015 and is convening an advisory committee next week to consider a second ap...

I was concerned that CMS finalized its Part B payment policy for biosimilars last year combining all biosimilars into on...

Today's hearing is a sequel to our Health Subcommittee's earlier review of the implementation progress of the Medicare p...